Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Colorectal Diseases(Electronic Edition) ›› 2019, Vol. 08 ›› Issue (04): 363-369. doi: 10.3877/cma.j.issn.2095-3224.2019.04.008

Special Issue:

• Original Article • Previous Articles     Next Articles

Study on the changes of somatic mutation in colorectal metastatic cancer based on COSMIC database

Zhengchun Kang1, Jifu E1,(), Liangliang Zhu1, Feihu Yan1, Enda Yu1,()   

  1. 1. Department of Colorectal Surgery, Changhai Hospital, PLA Navy Medical Uneversity, Shanghai 200433, China
  • Received:2018-10-23 Online:2019-08-25 Published:2019-08-25
  • Contact: Jifu E, Enda Yu
  • About author:
    Corresponding author: E Jifu, Email:
    Yu Enda, Email:

Abstract:

Objective

To screen the significant differences in somatic gene mutations between primary colorectal cancer and colorectal metastatic cancer using the Catalogue of Somatic Mutations In Cancer Catalog (COSMIC) Database and analyze its possible functions and pathways.

Methods

The colorectal cancer whole-exome sequencing data was downloaded from the COSMIC database. In the R 3.5.0 environment, the chi-square test or Fisher′ exact test was used to analysis the primary colorectal cancer and colorectal metastatic cancer. The differences in somatic mutation genes were mined, and somatically mutated genes with significant differences were recorded and functional and pathway enrichment analysis was performed to explore their possible biological functions and pathways.

Results

A total of 120 somatic mutations, including RHEB, RP11-368J21.2, AGAP10, etc, were found. The GO and KEGG enrichment analysis showed that these significant differences in somatic mutations may be related to dehydrogenase activity, reductase activity, cell cycle arrest, metabolic pathway, PI3K-Akt signaling pathway, cell cycle, cell adhesion molecules, transcriptional disorders in cancer, platinum resistance, and other functions and pathways.

Conclusion

The significant difference in somatic mutation between primary colorectal cancer and colorectal metastatic cancer can provide a reference for studying the metastasis mechanism of colorectal cancer. Significant differences in somatic mutations may be used as clinical diagnostic markers for metastatic colorectal cancer or as targets for metastasis therapy.

Key words: Colorectal neoplasms, Somatic mutation, Metastatic colorectal cancer

京ICP 备07035254号-20
Copyright © Chinese Journal of Colorectal Diseases(Electronic Edition), All Rights Reserved.
Tel: 0086-010-87788026 E-mail: cjcd_editor@vip.163.com
Powered by Beijing Magtech Co. Ltd